|
Name |
L-dihydroanticapsin
|
| Molecular Formula | C9H15NO4 | |
| IUPAC Name* |
(2S)-2-amino-3-[(1R,2S,5R,6S)-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]propanoic acid
|
|
| SMILES |
C1C[C@H]([C@H]2[C@@H]([C@@H]1C[C@@H](C(=O)O)N)O2)O
|
|
| InChI |
InChI=1S/C9H15NO4/c10-5(9(12)13)3-4-1-2-6(11)8-7(4)14-8/h4-8,11H,1-3,10H2,(H,12,13)/t4-,5-,6+,7+,8-/m0/s1
|
|
| InChIKey |
YMLXTGCTHGQQKS-TXXZRHAASA-N
|
|
| Synonyms |
L-dihydroanticapsin; CHEBI:85360; C20940; Q27158510; 3-[(1R,2S,5R,6S )-5-hydroxy-7-oxabicyclo[4.1.0]heptan-2-yl]-L-alanine
|
|
| CAS | NA | |
| PubChem CID | 86583396 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 201.22 | ALogp: | -3.1 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 96.1 | Aromatic Rings: | 2 |
| Heavy Atoms: | 14 | QED Weighted: | 0.549 |
| Caco-2 Permeability: | -6.023 | MDCK Permeability: | 0.00044032 |
| Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.578 |
| Human Intestinal Absorption (HIA): | 0.917 | 20% Bioavailability (F20%): | 0.006 |
| 30% Bioavailability (F30%): | 0.127 |
| Blood-Brain-Barrier Penetration (BBB): | 0.388 | Plasma Protein Binding (PPB): | 7.50% |
| Volume Distribution (VD): | 0.425 | Fu: | 83.30% |
| CYP1A2-inhibitor: | 0.025 | CYP1A2-substrate: | 0.042 |
| CYP2C19-inhibitor: | 0.037 | CYP2C19-substrate: | 0.059 |
| CYP2C9-inhibitor: | 0.016 | CYP2C9-substrate: | 0.218 |
| CYP2D6-inhibitor: | 0.033 | CYP2D6-substrate: | 0.182 |
| CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.028 |
| Clearance (CL): | 7.675 | Half-life (T1/2): | 0.813 |
| hERG Blockers: | 0.057 | Human Hepatotoxicity (H-HT): | 0.433 |
| Drug-inuced Liver Injury (DILI): | 0.034 | AMES Toxicity: | 0.019 |
| Rat Oral Acute Toxicity: | 0.117 | Maximum Recommended Daily Dose: | 0.034 |
| Skin Sensitization: | 0.419 | Carcinogencity: | 0.173 |
| Eye Corrosion: | 0.015 | Eye Irritation: | 0.104 |
| Respiratory Toxicity: | 0.884 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005742 | ![]() |
0.316 | D02UDJ | ![]() |
0.310 | ||
| ENC005743 | ![]() |
0.300 | D0P0QK | ![]() |
0.273 | ||
| ENC000767 | ![]() |
0.278 | D00ENY | ![]() |
0.260 | ||
| ENC000795 | ![]() |
0.245 | D0X5SI | ![]() |
0.245 | ||
| ENC000447 | ![]() |
0.245 | D01OPV | ![]() |
0.245 | ||
| ENC000550 | ![]() |
0.245 | D0XN8C | ![]() |
0.244 | ||
| ENC000760 | ![]() |
0.245 | D03CHT | ![]() |
0.241 | ||
| ENC000137 | ![]() |
0.245 | D05HXX | ![]() |
0.236 | ||
| ENC006058 | ![]() |
0.235 | D01JIA | ![]() |
0.235 | ||
| ENC001215 | ![]() |
0.235 | D0Z4EI | ![]() |
0.218 | ||